The Patent Finder

Northfield Liquidation Trust

Also on record
Records under this name other than patents Northfield Liquidation Trust holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Northfield Liquidation Trust

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,202,341Stabilized hemoglobin solutions
Formerly held
Lapsed on the fee record
Ended Apr 10, 2019 · USPTO record
Lapsed on the fee recordEnded Apr 10, 2019USPTO record
US 6,133,425Acellular red blood cell substitute
Formerly held
Term ended
Term ended Oct 17, 2017 · USPTO record
Term endedTerm ended Oct 17, 2017USPTO record
US 7,521,417Method and apparatus for preparing an acellular red blood cell substitute
Formerly held
Term ended
Ended no later than Mar 27, 2017 · USPTO record
Term endedEnded no later than Mar 27, 2017USPTO record
US 7,435,795Stabilized hemoglobin solutions
Formerly held
Lapsed on the fee record
Ended Oct 14, 2016 · USPTO record
Lapsed on the fee recordEnded Oct 14, 2016USPTO record
US 7,411,044Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing
Formerly held
Lapsed on the fee record
Ended Aug 12, 2016 · USPTO record
Lapsed on the fee recordEnded Aug 12, 2016USPTO record
US 7,291,592Method for treating patients with massive blood loss
Formerly held
Lapsed on the fee record
Ended Nov 6, 2015 · USPTO record
Lapsed on the fee recordEnded Nov 6, 2015USPTO record
US 6,498,141Method and apparatus for preparing an acellular red blood cell substitute
Formerly held
Lapsed on the fee record
Ended Dec 24, 2014 · USPTO record
Lapsed on the fee recordEnded Dec 24, 2014USPTO record
US 6,323,320Acellular red blood cell substitute
Formerly held
Lapsed on the fee record
Ended Nov 27, 2013 · USPTO record
Lapsed on the fee recordEnded Nov 27, 2013USPTO record
US 7,135,553Polymerized hemoglobin solutions having reduced amounts of tetramer and method for preparing
Formerly held
Lapsed on the fee record
Ended Nov 14, 2010 · USPTO record
Lapsed on the fee recordEnded Nov 14, 2010USPTO record
US 6,914,127Acellular red blood cell substitute
Formerly held
Term ended
Term ended Jul 2, 2007 · USPTO record
Term endedTerm ended Jul 2, 2007USPTO record
10 of 15 patents shown.
Pro members see all 15.
Pro members: see all 15 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited